UnitedHealthcare recently announced it would move forward with new coverage criteria for emergency-level care, which went into effect January 1, and this has drawn the ire of the American Hospital Association, which is urging UHC to rescind the policy….
The American Medical Association has added its voice in support of mandatory COVID-19 vaccinations in an amicus brief to the Supreme Court filed on December 30.
During the COVID-19 pandemic, Hispanic Medicare patients hospitalized with COVID-19 were more likely to die than non-Hispanic white Medicare beneficiaries, according to a study led by researchers from the Department of Health Care Policy in the Blavatn…
Through the bad — workforce shortages, lost revenue — and the good — the rise of telehealth and hospital at home models — COVID-19 changed, and will continue to change, the way hospitals and providers strategize their business models and care for p…
The open enrollment period in 2021 is outpacing all previous years in terms of enrollment, with a historic high of more than 13.6 million people already enrolled in health insurance coverage for 2022 through HealthCare.gov and state-based marketplaces …
The U.S. Food and Drug Administration has issued emergency use authorizations for Pfizer and Merck’s antiviral COVID-19 pills.
The FDA gave emergency use authorization to Pfizer’s pill on Wednesday and announced the Merck approval today.
The Supreme Court will hear oral arguments over federal vaccine mandates in a special session on Friday, January 7, 2022.
This is an unusual move by the justices to hear two cases to determine whether the mandates stand, as legal challenges move throug…
The Omicron variant of COVID-19 is the latest variant of concern in the global fight against the disease, but attitudes differ wildly about it – especially when it comes to vaccinated vs. unvaccinated individuals.
In a final rule issued on Tuesday, the Centers for Medicare and Medicaid Services has expanded access to certain durable medical equipment, such as continuous glucose monitors that increase diabetes treatment choices for people with Medicare.
Oracle’s acquisition of Cerner for $28.3 billion is positive for providers, as the deal’s primary objective is a decrease in the amount of time spent on electronic health records.
